Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies

Tao Zhang, Min Zhai, Jianbo Ji, Jian Zhang, Ye Tian, Xinyong Liu

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Ebola virus is one of the most threatening pathogens with the mortality rate as high as 90% in the world. There are no licensed therapeutic drugs or preventive vaccines for Ebola hemorrhagic fever up to date. Favipiravir, a novel antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection. In this review, we present an overview of recent progress on the treatment of Ebola virus disease with Favipiravir and describe its possible mechanism. Moreover, we give a brief summary of other related treatment strategies against Ebola.

Original languageEnglish
Pages (from-to)2364-2368
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume27
Issue number11
DOIs
StatePublished - 2017
Externally publishedYes

Keywords

  • Antiviral activity
  • Ebola virus
  • Favipiravir
  • Mechanism
  • Related strategies

Fingerprint

Dive into the research topics of 'Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies'. Together they form a unique fingerprint.

Cite this